drugset / Trial / NCT01012479
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if Candesartan, once daily (QD), added with Hydrochlorothiazide may be helpful in treating people with newly diagnosed severe essential hypertension.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-05
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan cilexetil | Unknown | 32 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | Oral |